Increased levels of soluble CD30 in plasma of patients with Plasmodium falciparum malaria

Kåre Kemp; Jørgen Kurtzhals; Bartholomew D Akanmori; Victoria Adabayeri; Bamenla Q Goka; Charlotte Behr; Lars Hviid

doi:10.1128/CDLI.9.3.720-722.2002

Increased levels of soluble CD30 in plasma of patients with Plasmodium falciparum malaria

Kåre Kemp, Jørgen Kurtzhals, Bartholomew D Akanmori, Victoria Adabayeri, Bamenla Q Goka, Charlotte Behr, Lars Hviid

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

4 Citationer (Scopus)

Abstract

Udgivelsesdato: 2002-May

Originalsprog	Engelsk
Tidsskrift	Clinical and Vaccine Immunology
Vol/bind	9
Udgave nummer	3
Sider (fra-til)	720-2
Antal sider	2
ISSN	1556-6811
DOI	https://doi.org/10.1128/CDLI.9.3.720-722.2002
Status	Udgivet - 2002

Bibliografisk note

Keywords: Animals; Antigens, CD30; Cells, Cultured; Child; Ghana; Humans; Interferon Type II; Malaria, Falciparum; Plasmodium falciparum; Solubility; T-Lymphocytes

Adgang til dokumentet

10.1128/CDLI.9.3.720-722.2002

Citationsformater

Increased levels of soluble CD30 in plasma of patients with Plasmodium falciparum malaria. / Kemp, Kåre; Kurtzhals, Jørgen; Akanmori, Bartholomew D; Adabayeri, Victoria; Goka, Bamenla Q; Behr, Charlotte; Hviid, Lars.

I: Clinical and Vaccine Immunology, Bind 9, Nr. 3, 2002, s. 720-2.

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

@article{e0ee9f7078c811dd81b0000ea68e967b,

title = "Increased levels of soluble CD30 in plasma of patients with Plasmodium falciparum malaria",

abstract = "Levels of soluble CD30 (sCD30) in serum were elevated in patients with Plasmodium falciparum malaria but showed decline following treatment. The levels of sCD30 in serum were correlated significantly with the expression of gamma interferon by peripheral T cells. These data suggest that CD30(+) cells are upregulated during a malaria attack and that they may play a regulating role at the site of inflammation.",

author = "K{\aa}re Kemp and J{\o}rgen Kurtzhals and Akanmori, {Bartholomew D} and Victoria Adabayeri and Goka, {Bamenla Q} and Charlotte Behr and Lars Hviid",

note = "Keywords: Animals; Antigens, CD30; Cells, Cultured; Child; Ghana; Humans; Interferon Type II; Malaria, Falciparum; Plasmodium falciparum; Solubility; T-Lymphocytes",

year = "2002",

doi = "10.1128/CDLI.9.3.720-722.2002",

language = "English",

volume = "9",

pages = "720--2",

journal = "Clinical and Diagnostic Laboratory Immunology",

issn = "1556-6811",

publisher = "American Society for Microbiology",

number = "3",

}

TY - JOUR

T1 - Increased levels of soluble CD30 in plasma of patients with Plasmodium falciparum malaria

AU - Kemp, Kåre

AU - Kurtzhals, Jørgen

AU - Akanmori, Bartholomew D

AU - Adabayeri, Victoria

AU - Goka, Bamenla Q

AU - Behr, Charlotte

AU - Hviid, Lars

N1 - Keywords: Animals; Antigens, CD30; Cells, Cultured; Child; Ghana; Humans; Interferon Type II; Malaria, Falciparum; Plasmodium falciparum; Solubility; T-Lymphocytes

PY - 2002

Y1 - 2002

N2 - Levels of soluble CD30 (sCD30) in serum were elevated in patients with Plasmodium falciparum malaria but showed decline following treatment. The levels of sCD30 in serum were correlated significantly with the expression of gamma interferon by peripheral T cells. These data suggest that CD30(+) cells are upregulated during a malaria attack and that they may play a regulating role at the site of inflammation.

AB - Levels of soluble CD30 (sCD30) in serum were elevated in patients with Plasmodium falciparum malaria but showed decline following treatment. The levels of sCD30 in serum were correlated significantly with the expression of gamma interferon by peripheral T cells. These data suggest that CD30(+) cells are upregulated during a malaria attack and that they may play a regulating role at the site of inflammation.

U2 - 10.1128/CDLI.9.3.720-722.2002

DO - 10.1128/CDLI.9.3.720-722.2002

M3 - Journal article

C2 - 11986285

VL - 9

SP - 720

EP - 722

JO - Clinical and Diagnostic Laboratory Immunology

JF - Clinical and Diagnostic Laboratory Immunology

SN - 1556-6811

IS - 3

ER -